Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Universe Pharmaceuticals (UPC) Receivables - Other (2021 - 2025)

Universe Pharmaceuticals' Receivables - Other history spans 4 years, with the latest figure at $2.3 billion for Q3 2025.

  • For Q3 2025, Receivables - Other fell 35.98% year-over-year to $2.3 billion; the TTM value through Sep 2025 reached $2.3 billion, down 35.98%, while the annual FY2025 figure was $2.3 billion, 35.98% down from the prior year.
  • Receivables - Other for Q3 2025 was $2.3 billion at Universe Pharmaceuticals, down from $3.6 billion in the prior quarter.
  • Across five years, Receivables - Other topped out at $3.6 billion in Q3 2024 and bottomed at $236982.0 in Q3 2021.
  • The 4-year median for Receivables - Other is $1.1 billion (2023), against an average of $1.5 billion.
  • The largest annual shift saw Receivables - Other surged 185421.16% in 2024 before it plummeted 35.98% in 2025.
  • A 4-year view of Receivables - Other shows it stood at $236982.0 in 2021, then surged by 710.29% to $1.9 million in 2023, then soared by 185421.16% to $3.6 billion in 2024, then tumbled by 35.98% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for UPC's Receivables - Other are $2.3 billion (Q3 2025), $3.6 billion (Q3 2024), and $1.9 million (Q3 2023).